Valion Bio Inc (VBIO) — Financial Flexibility Index
Latest as of December 2025:
-0.15x
Valion Bio Inc (VBIO) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of $-2.26 Million (operating CF $-2.29 Million minus capex $25.00K) represents 0% of total liabilities ($14.81 Million).
Financial Flexibility Index
-0.15x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-2.26 Million
Operating CF − Capex
Total Liabilities
$14.81 Million
USD
Capital Expenditures
$25.00K
USD
Valion Bio Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Valion Bio Inc across 7 annual periods. See Valion Bio Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Valion Bio Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Valion Bio Inc. For the full company profile including market capitalisation, see Valion Bio Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.43x | $-6.42 Million | $-7.00 Million | $14.81 Million | ▲ +97.9% |
| 2024 | -21.05x | $-5.72 Million | $-5.72 Million | $272.00K | ▼ -295.5% |
| 2023 | -5.32x | $-8.39 Million | $-8.51 Million | $1.58 Million | ▼ -34.1% |
| 2022 | -3.97x | $-8.91 Million | $-8.92 Million | $2.25 Million | ▲ +91.7% |
| 2020 | -48.00x | $-1.61 Million | $-1.61 Million | $33.44K | ▼ -1617.6% |
| 2019 | -2.79x | $-3.59 Million | $-3.59 Million | $1.28 Million | ▲ +65.8% |
| 2017 | -8.16x | $-2.89 Million | $-2.89 Million | $353.52K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities